AWM
BSX icon

Aevitas Wealth Management’s Boston Scientific BSX Stock Holding History

Aevitas Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$4K – 398
2018
Q3 		$4K Hold
100
– – ﹤0.01% 396
2018
Q2 		$3K Sell
100
-1,000
-91% -$30.2K ﹤0.01% 385
2018
Q1 		$30K Hold
1,100
– – 0.03% 218
2017
Q4 		$27K Buy
+1,100
New +$30.3K 0.03% 232

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Aevitas Wealth Management's BSX Position: Q4 2018 in Review

Aevitas Wealth Management sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 100 shares — an estimated $4K sold.

Aevitas Wealth Management first reported a position in BSX in Q4 2017 and held it in 4 quarters. The position peaked at $30K in Q1 2018. 730 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Aevitas Wealth Management reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Aevitas Wealth Management sold 100 Boston Scientific shares in Q4 2018, an estimated $4K.
  • Aevitas Wealth Management first reported a position in Boston Scientific in Q4 2017 and held it in 4 quarters.
  • Aevitas Wealth Management's Boston Scientific position peaked at $30K in Q1 2018.
  • 730 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Aevitas Wealth Management's 13F filing for Q4 2018, filed 14 Feb 2019.